Français
English
Search
Filter by Catégories
Choisir une catégorie
News
Opinions
Press release
Exact matches only
Search in title
Search in content
Search in comments
Search in excerpt
Filter by Custom Post Type
Français
English
About the CNS
Mission & organization
Members
Calendar
Frequently Asked Questions
Issues
News
Opinions
Screening
Prevention
International
Public action (France)
Global care
Press release
Folders
Index
Related websites
Contact
Search
Filter by Catégories
Choisir une catégorie
News
Opinions
Press release
Exact matches only
Search in title
Search in content
Search in comments
Search in excerpt
Filter by Custom Post Type
Home
/
Opinions
/
Public action (France)
/
Memorandum of Opinion on the Classification of Buprenorphine as a Narcotic
Previous
Next
Memorandum of Opinion on the Classification of Buprenorphine as a Narcotic
cnsadmin
2016-01-05T09:38:35+01:00
27 April 2006
|
Tags:
Drug addiction
,
Note
,
Opinion
,
Prevention
,
Public action
,
Réduction des risques
,
Substitution
|
Documents
Memorandum of Opinion on the Classification of Buprenorphine as a Narcotic
Français
News
Global health: CNS issues new Position paper
7 May 2019
IAS 2017: CNS Satellite Symposium
17 May 2017
International Conference AIDS 2016 in Durban
12 July 2016
More News
Upcoming Events
May
16
14h00
-
16h30
Plenary session
Jun
13
14h00
-
16h30
Plenary session
Jul
4
14h00
-
16h30
Plenary session
View Calendar
More Events
Folders
Criminalisation of HIV sexual transmission
Pre-exposure prophylaxis (PrEP)
Over-the-counter HIV “home tests”
HIV and sex trade
Illicit drug policies and risk reduction for infectious diseases
More folders
